Comparing blood pressure drugs after heart stent placement

This trial compares placing a tiny mesh tube (stent) to open the narrowed kidney artery versus continuing blood pressure medicines alone. It is for people whose high blood pressure is hard to control even with multiple medications and who have a blockage in the kidney artery that can be treated.

This study follows people who need a coronary (heart) stent to see how they do after treatment. It does not sound like an experimental drug trial for you—it’s mainly about collecting health information after a stent procedure.

This trial compares two blood-thinning medicines—clopidogrel and aspirin—after you have finished a short period of dual therapy following a special type of drug-eluting heart stent. It may help find which medicine works better and is safer for preventing future heart problems.

This trial compares two types of stents that release medicine to help keep arteries open after an acute coronary syndrome event (often called a heart attack or unstable angina). It tests whether the standard short course of two blood-thinning medicines for one month is enough, and which stent strategy works best.

This study tests whether angiotensin receptor blocker (ARB) blood pressure medication helps people with mild to moderate aortic stenosis (a narrowing of the heart’s main valve). It looks at safety and whether the treatment offers benefit for your heart and blood flow.

This study compares two treatment approaches for chronic coronary syndrome (narrowed heart arteries): adding a stent procedure to standard medications versus medications alone. The goal is to see which approach better prevents heart attacks and other serious heart events.